Senores Pharmaceuticals IPO Lot Size
The Senores Pharmaceuticals IPO is a book build issue with a total issue size of ₹582.11 cr, comprising of fresh issue of 12787723 equity shares., and a offer for sale of 2100000 equity shares. Senores Pharmaceuticals IPO opened for subscription on Dec 20, 2024 and closed on Dec 24, 2024. Senores Pharmaceuticals IPO is set price band at ₹372 to ₹391 per share, with a lot size of 38 shares. Minimum investment for Retail investors was ₹14,858.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on Dec 26, 2024, and listed on both the NSE and BSE on Dec 30, 2024.
MUFG Intime India Private Limited has been appointed as the registrar. Ambit Private Limited, Equirus Capital Private Limited and Nuvama Wealth Management Limited are the Book Running Lead Manager for the issue.
Before investing in the Senores Pharmaceuticals IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Senores Pharmaceuticals IPO Lot Size
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 38 | 14,858.00 |
| Retail (Max) | 13 | 494 | 193,154.00 |
| S-HNI (Min) | 14 | 532 | 208,012.00 |
| S-HNI (Max) | 67 | 2,546 | 995,486.00 |
| B-HNI (Min) | 68 | 2,584 | 1,010,344.00 |
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Senores Pharmaceuticals IPO is a Book-building IPO with a total issue size of ₹582.11 crore. The Senores Pharmaceuticals IPO price band is ₹372 to 391 per share. The Senores Pharmaceuticals IPO subscription opens on Fri, Dec 20, 2024, and closes on Tue, Dec 24, 2024. The Senores Pharmaceuticals IPO will be listed on the NSE,BSE. MUFG Intime India Private Limited is the registrar for the Senores Pharmaceuticals IPO.
The Senores Pharmaceuticals IPO opens on Fri, Dec 20, 2024 and closes on Tue, Dec 24, 2024
Senores Pharmaceuticals IPO Price Band is ₹372 to 391 per share.
Senores Pharmaceuticals IPO lot size is 38 shares, Retail investors need a minimum investment of ₹14858 based on the upper price band
The minimum investment for Senores Pharmaceuticals IPO is ₹14858, based on one lot of 38 shares at the upper price band of ₹391 per share.
Investors can apply for the Senores Pharmaceuticals IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Tue, Dec 24, 2024. The application amount remains blocked until the Senores Pharmaceuticals IPO allotment is finalized.
Senores Pharmaceuticals IPO issue size is ₹582.11 crores.
Senores Pharmaceuticals IPO allotment date is Wed, Jul 1, 2026.
The registrar for Senores Pharmaceuticals IPO is MUFG Intime India Private Limited. Investors can go to MUFG Intime India Private Limited website to check Senores Pharmaceuticals IPO allotment status, refund processing, and other IPO-related information.
The Senores Pharmaceuticals IPO GMP (Grey Market Premium) is ₹284 as of Mon, Dec 30, 2024. Based on the upper price band of ₹391 per share, the estimated Senores Pharmaceuticals IPO listing price is ₹675, indicating a potential listing gain of approximately 0% over the issue price.